Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments
Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors
BioTime, Inc. Announces Approval For NYSE Amex Listing
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on AGO, PTN, BJ, DTE, ZQK and HSP
StockPreacher.Com Issues Trading Outlook for Novadel Pharma Inc.
BenchmarkJournal.Com Free Analyst Review for AU, DOV, HSP, SNY, TCK and S
Bad Power Cords Prompt Hospira Recall
Hospira Launches Generic Oxaliplatin Injection
Hospira Reports Second-Quarter 2009 Results
Hospira Reports Second-Quarter 2009 Results
SuperGen Reports 2009 Second Quarter Financial Results
ICU Medical, Inc. To Acquire Hospira's Critical Care Product Line ; -- ICU Expects Acquisition to Be Accretive to 2009 Earnings --; -- Hospira to Focus Future Growth and Innovation in Streamlined Product Line --
ICU Medical, Inc. to Acquire Hospira's Critical Care Product Line
Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
Hospira Receives FDA Approval for Azithromycin for Injection
Hospira to Host Conference Call for Second-Quarter 2009 Results
Hospira Receives Favorable Court Decision on Eloxatin(R)
Healthcare Industry Is Not Unaffected By Economy
Hospira to Present at Upcoming Investor Conferences
Hospira Announces Plans to Integrate Symbiq(R) and EndoTool(R) Technologies
Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
Hospira Receives FDA Approval for 10 Gram Vial of Sterile Vancomycin Hydrochloride, USP
Hospira to Present at Bank of America and Merrill Lynch 2009 Health Care Conference May 13
Hospira Launches Biologics 'Clock' and Web Resource to Raise Awareness of Potential Biogenerics' Impact
Hospira Reports First-Quarter 2009 Results - Apr 28 2009 11:56AM
Hospira Reports First-Quarter 2009 Results - Apr 28 2009 7:54AM
Hospira Reports First-Quarter 2009 Results
Hospira Names Brian Meadows Supply Chain Chief
Beacon Equity Issues Trade Alerts on Medical Device Stocks: ABT, BSX, JNJ, BAX, HSP, ZMH
Hospira to Host Conference Call for First-Quarter 2009 Results
Hospira Announces Plans to Optimize Operations, Increase Shareholder Value
Hospira to Host Investor Conference Call March 24, 2009
Hospira Supports Newly Introduced Biogenerics Legislation
Hospira to Present at Cowen and Company's 29th Annual Health Care Conference March 17
Hospira Expands Board of Directors - Mar 9 2009 3:05PM
Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
Hospira Reports Fourth-Quarter and Full-Year 2008 Results
Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
Hospira to Present at J.P. Morgan's 27th Annual Healthcare Conference January 14
Hospira Names Ken Meyers to Lead Human Resources
Hospira Reports Third-Quarter 2008 Results
Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) Injection
StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
Hospira Acquires EndoTool From MD Scientific
Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
Zacks Analyst Blog Highlights: Hospira, Inc., Finisar Corp., McDonald's Corp., Cleveland-Cliffs, Inc. And Alpha Natural Resources, Inc.
Hospira to Present at the Morgan Stanley 2008 Healthcare Conference on September 9
Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
Hospira Reports Second-Quarter 2008 Results
Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
Hospira Names Dr. Sumant Ramachandra Chief Scientific Officer
Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders - Jun 1 2008 10:32PM
Hospira Reports First-quarter 2008 Results - Jun 1 2008 10:31PM
Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
Hospira Acquires Sculptor
Hospira Hosts Conference Call for First-Quarter 2008 Earnings
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia